Celularity (CELUW) Change in Account Payables (2020 - 2025)
Celularity (CELUW) reported Change in Account Payables of $1.8 million for Q4 2025, down 76.85% year-over-year from $7.9 million in Q4 2024, and up 881.28% quarter-over-quarter from $187000.0 in Q3 2025.
Celularity (CELUW) Change in Account Payables (2020 - 2025) Analysis & Trends
Celularity (CELUW) has 6 years of Change in Account Payables data on file, last reported at $1.8 million in Q4 2025.
- Change in Account Payables for Q4 2025 came in at $1.8 million, down 76.85% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.1 million (down 66.17% YoY), and the FY2025 annual result was $3.1 million, down 66.17% from the prior year.
- Change in Account Payables advanced to $1.8 million in Q4 2025 per CELUW's latest filing, from $187000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $7.9 million in Q4 2024 and troughed at -$3.2 million in Q4 2022.
- A 5-year average of $1.0 million and a median of $931000.0 in 2024 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2021 and 2022: Change in Account Payables jumped 2033.77% in 2021, then tumbled 297.5% in 2022.
- A 5-year view of Change in Account Payables shows it stood at $1.6 million in 2021, then plunged by 297.5% to -$3.2 million in 2022, then jumped by 153.71% to $1.7 million in 2023, then jumped by 354.79% to $7.9 million in 2024, then slumped by 76.85% to $1.8 million in 2025.
- Business Quant data shows CELUW's Change in Account Payables at $1.8 million in Q4 2025, $187000.0 in Q3 2025, and $1.1 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -9.42 Mn |
| 10 | Celularity | - | - | -3.27 Mn | 1.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.84 Mn |
| Dec 31, 2025 | 1.84 Mn |
| Sep 30, 2025 | 187,000.00 |
| Sep 30, 2025 | 187,000.00 |
| Jun 30, 2025 | 1.09 Mn |
| Jun 30, 2025 | 1.09 Mn |
| Mar 31, 2025 | 17,000.00 |
| Mar 31, 2025 | 17,000.00 |
| Dec 31, 2024 | 7.93 Mn |
| Dec 31, 2024 | 7.93 Mn |
| Sep 30, 2024 | 1.71 Mn |
| Sep 30, 2024 | 1.71 Mn |
| Jun 30, 2024 | 775,000.00 |
| Jun 30, 2024 | 775,000.00 |
| Mar 31, 2024 | -1.17 Mn |
| Mar 31, 2024 | -1.17 Mn |
| Dec 31, 2023 | 1.74 Mn |
| Dec 31, 2023 | 1.74 Mn |
| Sep 30, 2023 | 711,000.00 |
| Sep 30, 2023 | 711,000.00 |